| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.26 | 0.0007 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0009 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.092 | 0.002 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.15 | 0.002 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.088 | 0.003 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.092 | 0.003 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.15 | 0.003 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.087 | 0.004 |